WhizAI Raises $4M to Bring Cognitive Insights to Life Sciences
Somerset, NJ, July 27, 202-- WhizAI, the first and only purpose-built cognitive insights platform for the life sciences, today announces $4 million in seed funding led by Healthy Ventures, with participation from Bling Capital, Firebolt Ventures and existing investors. This investment brings the total raised by the company to over $6.5 million.
The world’s leading global pharmaceutical companies rely on WhizAI to empower their commercial teams and leadership with 100x faster access to insights when compared to traditional business intelligence applications. With WhizAI, users can simply ask questions in their own language. This is achieved with AI that is pre-trained on life sciences vernacular and data. The product combines AI for natural language processing, data modeling, data visualization and anomaly detection into a single platform for cognitive insights.
“Our cognitive insights platform is fundamentally changing the way life sciences users analyze data and consume business insights. The days of data silos, piecemeal analytics, dashboard deluges and extensive software training are over. This funding enables us to expedite our sales footprint and execute on our product vision,” said Rohit Vashisht, co-founder and CEO, WhizAI.
Anya Schiess, founder and general partner of Healthy Ventures, adds, “The life sciences industry is increasingly running on data, yet major companies keep telling us they can’t make use of it all. We were delighted to find that Rohit and Amitabh, two seasoned entrepreneurs with decades of experience in business intelligence, built a product to solve this problem exactly. WhizAI’s platform is deeply powerful, yet magically easy to use. It is already transforming and deepening the relationship between business users and data insights.
”Fast, easy and contextual, WhizAI is a leap forward in business intelligence software for life sciences through its combination of AI, machine learning and scalability. The company will use this seed capital to grow its industry footprint by expanding its team across the globe and investing in sales and marketing. As part of the financing, Anya Schiess will join WhizAI’s Board of Directors.To learn more, please visit www.whiz.ai.
About WhizAI: WhizAI is the first and only purpose-built cognitive insights platform for life sciences, empowering users to get answers to their business questions by simply asking via voice, text on web and mobile. WhizAI is trained on the language and data of life sciences, enabling it to answer even the most complex questions from billions of records in seconds. Fast, easy, and scalable, WhizAI is the trusted partner of choice at the top global life sciences companies. Asked. Answered. Instantly. Learn more at www.whiz.ai.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with AI-Powered Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Where Gartner Positions Natural Language Query on the Hype Cycle and What It Means for Life Sciences
Gartner® 2022 Hype Cycle™ for Natural Language Technologies (NLT) shows natural language query (NLQ) adoption is accelerating. WhizAI was recently recognized as a Sample Vendor in the Natural Language Query category in several Gartner Hype Cycles:
AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster
Today’s commercial teams must pinpoint top opportunities in markets across the country—or across the world—based on regulations, drug trials, market activity, competitors, insurance records, HCP preferences and affiliations, much more data than is humanly possible to manage.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.